Predictive and prognostic cancer biomarkers revisited
- 1 July 2015
- journal article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 15 (8) , 971-974
Abstract
While both prognostic and predictive cancer biomarkers predict clinical outcome, the term ‘predictive biomarker’ is reserved for the association of a specific therapy with a specific clinical outco...Keywords
This publication has 24 references indexed in Scilit:
- Reproducible research can still be wrong: Adopting a prevention approachProceedings of the National Academy of Sciences, 2015
- Science Isn't Science If It Isn't ReproducibleThe American Journal of Pathology, 2015
- Biomarkers and Oncology: The Path Forward to a Learning Health SystemArchives of Pathology & Laboratory Medicine, 2014
- Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?BMC Medicine, 2014
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyOncogene, 2013
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationBMC Medicine, 2012
- Bioinformatics advances for clinical biomarker developmentExpert Opinion on Medical Diagnostics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Clinical trials for predictive medicine: new challenges and paradigmsClinical Trials, 2010
- Clinical Utility of Epidermal Growth Factor Receptor Expression for Selecting Patients with Advanced Non-small Cell Lung Cancer for Treatment with ErlotinibJournal of Thoracic Oncology, 2006